IP Library › Granted Patent US 12,109,430
Granted Patent B2
US 12,109,430 · App. 17/243,865 · Granted Oct 8, 2024

Animal treatment apparatus, phototherapeutic apparatus, and animal treatment method

Inventors: Shinpei Kawarai (Sagamihara, JP); Atsushi Tsukamoto (Sagamihara, JP); Shota Kubota (Sagamihara, JP); Yasuo Fujikawa (Yokohama, JP); Tomohiro Tsurumoto (Yokohama, JP); Makiko Yamagishi (Azumino, JP)
Assignee: NICHIA CORPORATION
A61N5/0616A61N2005/0626A61N2005/0652A61N2005/0661
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,109,430
App. No.
17/243,865
Granted
Oct 8, 2024
Kind
B2
Abstract

A method of treating a non-human animal subject includes irradiating, one or more times, light having a peak wavelength in a range of 315-335 nm to an affected area of the animal subject.

Claims (21)

1. A method of treating a non-human animal subject, comprising:

performing a first step comprising irradiating an affected area of skin of the non-human animal subject with light having a first peak wavelength, which is in a range of 315-335 nm at a first irradiation dose; and

one or more days after the first step, performing a second step comprising irradiating the affected area of the skin with light having a second peak wavelength in the range of 315-335 nm at a second irradiation dose, wherein the second peak wavelength is shorter than the first peak wavelength.

2. The method according to claim 1 , wherein:

the first peak wavelength is in a range of 325-335 nm, and

the second peak wavelength is in a range of 315-325 nm.

3. The method according to claim 1 , wherein the light irradiated in the first and second steps has a relative illuminance at wavelengths less than 315 nm of 30% or less.

4. The method according to claim 1 , wherein the method is used to treat a disease or disorder mediated by MrgprX2 gene.

5. The method according to claim 1 , wherein the method is used to treat a disease or disorder selected from the group consisting of allergic dermatitis, cutaneous lymphoma, vitiligo, a wound, alopecia, an infectious disease, a skin abscess, and pyoderma.

6. The method according to claim 1 , wherein the first step further comprises irradiating the affected area with the light having the first peak wavelength at a third irradiation dose that is higher than the first irradiation dose.

7. The method according to claim 6 , wherein:

the first irradiation dose is 300 mJ/cm 2 or less, and

the third irradiation dose is more than 300 mJ/cm 2 but less than an irradiation dose that would cause sunburn to the skin.

8. The method according to claim 6 , wherein the first step further comprises repeating the step defined in claim 6 , with the third irradiation dose increasing each repetition.

9. The method according to claim 1 , wherein the second step further comprises irradiating the affected area with the light having the second peak wavelength at a fourth irradiation dose that is higher than the second irradiation dose.

10. The method according to claim 9 , wherein the second step further comprises repeating the step defined in claim 8 , with the fourth irradiation dose increasing each repetition.

11. The method according to claim 1 , further comprising performing a third step comprising irradiating the affected area with light having a third peak wavelength in a range of 305-315 nm at a fifth irradiation dose.

12. The method according to claim 11 , wherein the third step further comprises irradiating the affected area with the light having the third peak wavelength at a sixth irradiation dose that is higher than the fifth irradiation dose.

13. The method according to claim 12 , wherein the third step further comprises repeating the step defined in claim 11 , with the sixth dose increasing each repetition.

14. The method according to claim 11 , wherein the fifth irradiation dose is 300 mJ/cm 2 or less.

15. The method according to claim 1 , wherein the light having a peak wavelength in the range of 315-335 nm is emitted by a light emitting diode (LED) or laser diode (LD).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2021
From: KAWARAI, SHINPEI; TSUKAMOTO, ATSUSHI; KUBOTA, SHOTA
To: SCHOOL CORPORATION, AZABU VETERINARY MEDICINE EDUCATIONAL INSTITUTION
Reel/Frame 056082/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2021
From: FUJIKAWA, YASUO; TSURUMOTO, TOMOHIRO; YAMAGISHI, MAKIKO
To: NICHIA CORPORATION
Reel/Frame 056082/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2021
From: SCHOOL CORPORATION, AZABU VETERINARY MEDICINE EDUCATIONAL INSTITUTION
To: NICHIA CORPORATION
Reel/Frame 056082/0493 →
Priority Claims (2)
JP 2018-206015 · Oct 31, 2018 · national
JP 2019-139154 · Jul 29, 2019 · national
Continuity (2)
Continuation PCTJP2019042636 · Oct 30, 2019
Related Publication 20210275826A1 · Sep 9, 2021
Cited By (1)
US 12,702,857